Research And Development Expense of Legend Biotech Corp from 31 Dec 2018 to 31 Mar 2024

Taxonomy & unit: ifrs-full: USD
Summary: Legend Biotech Corp quarterly and annual Research And Development Expense in USD history and change rate from 31 Dec 2018 to 31 Mar 2024.
Legend Biotech Corp Research And Development Expense for the quarter ending 31 Mar 2024 was $100,964,000, a 19% increase year-over-year.
Legend Biotech Corp annual Research And Development Expense for 2023 was $382,218,000, a 14% increase from 2022.
Legend Biotech Corp annual Research And Development Expense for 2022 was $335,648,000, a 7.1% increase from 2021.
Legend Biotech Corp annual Research And Development Expense for 2021 was $313,346,000, a 35% increase from 2020.
Source SEC data: View on sec.gov

Research And Development Expense, Quarterly (USD)

Research And Development Expense, YoY Quarterly Change (%)

Research And Development Expense, Annual (USD)

Research And Development Expense, YoY Annual Change (%)

Legend Biotech Corp Quarterly Research And Development Expense (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2024		$100,964,000	+$16,075,000	+19%	01 Jan 2024	31 Mar 2024	6-K	13 May 2024	2024	Q1
Q1 2023		$84,889,000			01 Jan 2023	31 Mar 2023	6-K	13 May 2024	2024	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2023	$382,218,000	+$46,570,000	+14%	01 Jan 2023	31 Dec 2023	20-F	19 Mar 2024	2023	FY
2022	$335,648,000	+$22,302,000	+7.1%	01 Jan 2022	31 Dec 2022	20-F	19 Mar 2024	2023	FY
2021	$313,346,000	+$81,186,000	+35%	01 Jan 2021	31 Dec 2021	20-F	19 Mar 2024	2023	FY
2020	$232,160,000	+$70,217,000	+43%	01 Jan 2020	31 Dec 2020	20-F	30 Mar 2023	2022	FY
2019	$161,943,000	+$101,306,000	+167%	01 Jan 2019	31 Dec 2019	20-F/A	17 Feb 2023	2021	FY
2018	$60,637,000			01 Jan 2018	31 Dec 2018	20-F	02 Apr 2021	2020	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.